Mechanism and prediction of HCC development in HBV infection

Weiqi Xu1, Jun Yu2, Vincent Wai-Sun Wong2

  • 1State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

Insights

Chronic hepatitis B virus (HBV) infection is a major cause of liver cancer (HCC). Prediction scores help identify low-risk individuals, but their effectiveness varies across ethnicities and needs further validation with new biomarkers.

Area of Science:

  • Hepatology
  • Oncology
  • Virology

Background:

  • Chronic hepatitis B virus (HBV) infection is a primary driver of hepatocellular carcinoma (HCC) worldwide.
  • Risk factors for HCC in chronic HBV patients include host and viral elements.
  • Existing HCC prediction scores offer value in identifying low-risk individuals for reduced surveillance.

Purpose of the Study:

  • To evaluate the performance of existing HCC prediction scores.
  • To assess the applicability of these scores in diverse populations.
  • To explore the potential of novel biomarkers in HCC risk stratification.

Main Methods:

  • Review of existing literature on HCC risk factors and prediction models.
  • Analysis of studies validating HCC prediction scores in different ethnic groups.
  • Investigation of emerging genetic and virological markers for HCC.

Main Results:

  • HCC prediction scores demonstrate high negative predictive value for low-risk groups.
  • Conflicting results exist regarding score performance in Caucasian versus Asian populations.
  • New genetic and virological markers show promise but are not yet in clinical use.

Conclusions:

  • Current HCC prediction scores are useful but require population-specific validation.
  • Further research is needed to integrate novel biomarkers into clinical practice for improved HCC risk assessment in chronic HBV patients.